VEGF189 overexpression in breast cancer cells delays metastasis
Source: NCBI BioProject (ID PRJNA165149)

0 0

Project name: Homo sapiens
Description: Vascular endothelial growth factor is a multifunctional cytokine playing important roles in angiogenesis, tumor progression and metastasis. Alternative splicing results in the production of several different isoforms of VEGF. We have previously generated human breast cancer cells overexpressing VEGF165 or VEGF189 isoforms (referred to as the V165 and V189 clones, respectively) and showed that VEGF189-transfected cells were less tumorigenic. In this study, we used bioluminescence imaging to analyze the metastasis capacity of breast cancer cell lines (MDA-MB-321) overexpressing VEGF isoforms in nude mice. V165, V189 and control cV clones were transfected with a luciferase plasmid to generate bioluminescent clones (the V165-B, V189-B and cV clones, respectively). These clones were then injected into the left heart ventricle of nude mice.Overall design: Human MDA-MB-231 breast cancer cells were used to generate stable transfected clones overexpressing VEGF165 isoform, VEGF189 isoform, or control vector (referred to as 42ctl8, 13ctl3 and PCIctl3, respectively).Analysis of the metastasis capacity of these clones in nude mice. Lung metastasis overexpressing VEGF165 isoform, VEGF189 isoform, or control vector (referred to as 42B45, 13B31 and PCIB9, respectively)were also analysed.
Data type: Transcriptome or Gene expression
Sample scope: Multiisolate
Relevance: Medical
Organization: Inserm U965
Literatures
  1. PMID: 26196186
Last updated: 2012-05-10